Literature DB >> 17442490

Inhibition by the chromaffin cell-derived peptide serine-histogranin in the rat's dorsal horn.

Ian D Hentall1, Walter A Hargraves, Jacqueline Sagen.   

Abstract

The heptadecapeptide histogranin, synthesized by adrenal chromaffin cells, is implicated in the analgesia produced by transplanting chromaffin cells into the spinal cord, including block of hyperalgesia mediated by NMDA-subtype glutamate receptors. To examine the neurophysiological basis for this analgesia, we applied the stable analog [Ser(1)]-histogranin (SHG) by iontophoresis near extracellularly recorded wide-dynamic range (WDR) neurons in anesthetized rats. When SHG was applied during peripheral electrical stimulation of A and C fibers at 0.1Hz, the C-fiber response was significantly inhibited but the A-fiber response was unaffected. SHG also opposed the NMDA-receptor-dependent post-tetanic facilitation (wind-up) of C-fiber responses produced by increasing the rate of peripheral afferent stimulation to 1Hz for 20s. To test whether block of NMDA-subtype receptors could be wholly or partially responsible for this suppression, SHG was applied during sequential pulsed iontophoresis of three agonists targeting distinct excitatory synaptic receptors: NMDA, kainate and substance P. All three excitatory effects were reversed by SHG; this reversal outlasted the 10-30min observation period when higher SHG doses were applied (>60nA). Histogranin therefore probably produces prolonged spinal analgesia by opposing the basal and potentiating synaptic effects of C-fibers on dorsal horn neurons. Actions besides or in addition to NMDA-receptor antagonism (e.g., agonism at inhibitory postsynaptic receptors or block of voltage-gated cation channels on C-fibers) are implied by the diversity of excitatory transmitters opposed by SHG.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442490      PMCID: PMC1945824          DOI: 10.1016/j.neulet.2007.03.056

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  22 in total

1.  Interactions of histogranin and related peptides with dopamine D2 receptor in rat brain membranes.

Authors:  H Ruan; S Lemaire
Journal:  Synapse       Date:  2001-03-01       Impact factor: 2.562

2.  Adrenal medullary transplants reduce formalin-evoked c-fos expression in the rat spinal cord.

Authors:  Julie B Siegan; Uri Herzberg; Beata R Frydel; Jacqueline Sagen
Journal:  Brain Res       Date:  2002-07-19       Impact factor: 3.252

3.  Characterization, localization and possible anti-inflammatory function of rat histone H4 mRNA variants.

Authors:  René Poirier; Irma Lemaire; Simon Lemaire
Journal:  FEBS J       Date:  2006-09       Impact factor: 5.542

4.  Alterations in rat spinal cord cGMP by peripheral nerve injury and adrenal medullary transplantation.

Authors:  J B Siegan; A T Hama; J Sagen
Journal:  Neurosci Lett       Date:  1996-08-30       Impact factor: 3.046

5.  Spinal allografts of adrenal medulla block nociceptive facilitation in the dorsal horn.

Authors:  I D Hentall; B R Noga; J Sagen
Journal:  J Neurophysiol       Date:  2001-04       Impact factor: 2.714

6.  NMDA-induced spinal hypersensitivity is reduced by naturally derived peptide analog [Ser1]histogranin.

Authors:  A T Hama; J B Siegan; U Herzberg; J Sagen
Journal:  Pharmacol Biochem Behav       Date:  1999-01       Impact factor: 3.533

7.  Analgesia induced by isolated bovine chromaffin cells implanted in rat spinal cord.

Authors:  J Sagen; G D Pappas; H B Pollard
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

8.  Proportional secretion of opioid peptides and catecholamines from adrenal chromaffin cells in culture.

Authors:  S P Wilson; K J Chang; O H Viveros
Journal:  J Neurosci       Date:  1982-08       Impact factor: 6.167

9.  Altered sodium channel expression in second-order spinal sensory neurons contributes to pain after peripheral nerve injury.

Authors:  Bryan C Hains; Carl Y Saab; Joshua P Klein; Matthew J Craner; Stephen G Waxman
Journal:  J Neurosci       Date:  2004-05-19       Impact factor: 6.167

Review 10.  Histogranin, a modified histone H4 fragment endowed with N-methyl-D-aspartate antagonist and immunostimulatory activities.

Authors:  S Lemaire; C Rogers; M Dumont; V K Shukla; C Lapierre; J Prasad; I Lemaire
Journal:  Life Sci       Date:  1995-03-03       Impact factor: 5.037

View more
  6 in total

1.  Combinations of intrathecal gamma-amino-butyrate receptor agonists and N-methyl-d-aspartate receptor antagonists in rats with neuropathic spinal cord injury pain.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  Eur J Pharmacol       Date:  2012-03-16       Impact factor: 4.432

2.  Sustained analgesic peptide secretion and cell labeling using a novel genetic modification.

Authors:  Shyam Gajavelli; Daniel A Castellanos; Orion Furmanski; Paul C Schiller; Jacqueline Sagen
Journal:  Cell Transplant       Date:  2008       Impact factor: 4.064

3.  Viral vectors encoding endomorphins and serine histogranin attenuate neuropathic pain symptoms after spinal cord injury in rats.

Authors:  Farinaz Nasirinezhad; Shyam Gajavelli; Blake Priddy; Stanislava Jergova; James Zadina; Jacqueline Sagen
Journal:  Mol Pain       Date:  2015-01-07       Impact factor: 3.395

4.  Experimental Gene Therapy with Serine-Histogranin and Endomorphin 1 for the Treatment of Chronic Neuropathic Pain.

Authors:  Stanislava Jergova; Catherine E Gordon; Shyam Gajavelli; Jacqueline Sagen
Journal:  Front Mol Neurosci       Date:  2017-12-08       Impact factor: 5.639

5.  Recombinant neural progenitor transplants in the spinal dorsal horn alleviate chronic central neuropathic pain.

Authors:  Stanislava Jergova; Shyam Gajavelli; Nirmal Pathak; Jacqueline Sagen
Journal:  Pain       Date:  2016-04       Impact factor: 7.926

Review 6.  Glial-Neuronal Interactions in Pathogenesis and Treatment of Spinal Cord Injury.

Authors:  Nadezda Lukacova; Alexandra Kisucka; Katarina Kiss Bimbova; Maria Bacova; Maria Ileninova; Tomas Kuruc; Jan Galik
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.